VistaGen Therapeutics (VTGN) Granted US Patent Related to Methods for Treating Depression with PH10 - StreetInsider.com

Submitted by Anonymous (not verified) on Wed, 02/13/2019 - 13:36

VistaGen Therapeutics (VTGN) Granted US Patent Related to Methods for Treating Depression with PH10  StreetInsider.comGet instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. VistaGen Therapeutics (NASDAQ: VTGN) today ...